Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Rodriguez-Antona

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Drug Metabolism and Personalized Therapy|December 8, 2015
The role of pharmacogenetics and pharmacogenomics in 21st-century medicine: state of the art and new challenges discussed in the VII Conference of the Spanish Pharmacogenetics and Pharmacogenomics Society (SEFF)Cristina Rodriguez-Antona
CNS Drugs|March 27, 2009
Cytochrome P450 2D6 genotyping: potential role in improving treatment outcomes in psychiatric disordersJulia Kirchheiner, Cristina Rodriguez-Antona
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 13, 2005
Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapyMagnus Ingelman-Sundberg, Cristina Rodriguez-Antona
Seminars in Oncology|August 27, 2013
Molecular markers to predict response to therapyJesus Garcia-Donas, Cristina Rodriguez-Antona, Eric Jonasch
Drug News & Perspectives|February 15, 2007
Novel aspects of drug metabolism and transportLovisa Afzelius, Magnus Ingelman-Sundberg, Maria Karlgren, et al.
NPJ Genomic Medicine|February 19, 2022
Clinical pharmacogenetic analysis in 5,001 individuals with diagnostic Exome Sequencing dataJavier Lanillos, Marta Carcajona, Paolo Maietta, et al.
Pharmacology & Therapeutics|November 16, 2007
Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspectsMagnus Ingelman-Sundberg, Sarah C Sim, Alvin Gomez, et al.
The Journal of Biological Chemistry|June 7, 2005
A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1Cristina Rodriguez-Antona, Magnus Axelson, Charlotta Otter, et al.
Human Genetics|October 14, 2009
Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatmentCristina Rodriguez-Antona, Alvin Gomez, Maria Karlgren, et al.
Radiology and Oncology|January 16, 2018
Association between <i>SLC19A1</i> Gene Polymorphism and High Dose Methotrexate Toxicity in Childhood Acute Lymphoblastic Leukaemia and Non Hodgkin Malignant Lymphoma: Introducing a Haplotype based ApproachBarbara Faganel Kotnik, Janez Jazbec, Petra Bohanec Grabar, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Drug Metabolism and Personalized Therapy|December 8, 2015
The role of pharmacogenetics and pharmacogenomics in 21st-century medicine: state of the art and new challenges discussed in the VII Conference of the Spanish Pharmacogenetics and Pharmacogenomics Society (SEFF)Cristina Rodriguez-Antona
CNS Drugs|March 27, 2009
Cytochrome P450 2D6 genotyping: potential role in improving treatment outcomes in psychiatric disordersJulia Kirchheiner, Cristina Rodriguez-Antona
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 13, 2005
Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapyMagnus Ingelman-Sundberg, Cristina Rodriguez-Antona
Seminars in Oncology|August 27, 2013
Molecular markers to predict response to therapyJesus Garcia-Donas, Cristina Rodriguez-Antona, Eric Jonasch
Drug News & Perspectives|February 15, 2007
Novel aspects of drug metabolism and transportLovisa Afzelius, Magnus Ingelman-Sundberg, Maria Karlgren, et al.
NPJ Genomic Medicine|February 19, 2022
Clinical pharmacogenetic analysis in 5,001 individuals with diagnostic Exome Sequencing dataJavier Lanillos, Marta Carcajona, Paolo Maietta, et al.
Pharmacology & Therapeutics|November 16, 2007
Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspectsMagnus Ingelman-Sundberg, Sarah C Sim, Alvin Gomez, et al.
The Journal of Biological Chemistry|June 7, 2005
A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1Cristina Rodriguez-Antona, Magnus Axelson, Charlotta Otter, et al.
Human Genetics|October 14, 2009
Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatmentCristina Rodriguez-Antona, Alvin Gomez, Maria Karlgren, et al.
Radiology and Oncology|January 16, 2018
Association between <i>SLC19A1</i> Gene Polymorphism and High Dose Methotrexate Toxicity in Childhood Acute Lymphoblastic Leukaemia and Non Hodgkin Malignant Lymphoma: Introducing a Haplotype based ApproachBarbara Faganel Kotnik, Janez Jazbec, Petra Bohanec Grabar, et al.
Pageof 6